dc.contributor.author | Nane, Ismet | |
dc.contributor.author | Oktar, Tayfun Mevlüt | |
dc.contributor.author | Oguz, Fatma | |
dc.contributor.author | Tugrul, Kamil Mehmet | |
dc.contributor.author | Tefik, Tzevat | |
dc.contributor.author | Karadeniz, Meltem Savran | |
dc.contributor.author | Turkmen, Aydin | |
dc.contributor.author | Ciftci, Hayriye | |
dc.date.accessioned | 2021-03-04T14:44:16Z | |
dc.date.available | 2021-03-04T14:44:16Z | |
dc.identifier.citation | Karadeniz M. S. , Ciftci H., Tefik T., Oktar T. M. , Nane I., Turkmen A., Oguz F., Tugrul K. M. , "Effects of Different Volatile Anesthetics on Cytokine and Chemokine Production After Ischemia-Reperfusion Injury in Patients Undergoing Living-Donor Kidney Transplant", EXPERIMENTAL AND CLINICAL TRANSPLANTATION, cilt.17, ss.68-74, 2019 | |
dc.identifier.issn | 1304-0855 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_831c996f-942f-4b0e-8bcc-5fc8cb8508aa | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/89264 | |
dc.identifier.uri | https://doi.org/10.6002/ect.mesot2018.o10 | |
dc.description.abstract | Objectives: Renal transplant is the treatment of choice for patients with end-stage renal disease. Ischemia-reperfusion damage is a major cause of early renal dysfunction during the perioperative period. lschemic hypoxic damage increases local inflammation, leading to secretion of cytokines and chemokines. Anesthetic conditioning is a widely described strategy to attenuate ischemia-reperfusion injury. Here, we compared the effects of desflurane and sevoflurane on serum proinflammatory cytokines and urine chemokines in living-donor kidney transplant recipients. | |
dc.language.iso | eng | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Health Sciences | |
dc.subject | Transplantation | |
dc.subject | Tıp | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Klinik Tıp | |
dc.subject | TRANSPLANTASYON | |
dc.title | Effects of Different Volatile Anesthetics on Cytokine and Chemokine Production After Ischemia-Reperfusion Injury in Patients Undergoing Living-Donor Kidney Transplant | |
dc.type | Makale | |
dc.relation.journal | EXPERIMENTAL AND CLINICAL TRANSPLANTATION | |
dc.contributor.department | İstanbul Üniversitesi , , | |
dc.identifier.volume | 17 | |
dc.identifier.startpage | 68 | |
dc.identifier.endpage | 74 | |
dc.contributor.firstauthorID | 27235 | |